Open AccessHow Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?
Author(s) -
Scott D. Grosse,
Guy Van Vliet
Publication year - 2006
Publication title -
hormone research in paediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000098400
Subject(s) - congenital adrenal hyperplasia , medicine , newborn screening , pediatrics , cohort , infant mortality , wasting , population , environmental health
Congenital adrenal hyperplasia (CAH) is increasingly being included in newborn screening programs. Screening can prevent neonatal mortality in children with salt-wasting CAH, but the number of deaths prevented is not known. Cost-effectiveness analyses of screening require estimates of the probability of mortality in CAH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom